George YancopoulosUS

Bd. Co-Chair, President & CSO, REGENERON PHARMACEUTICALS, INC. (REGN)

Net worth (est.)
$717.2M
#290 in the US
¥113B · US-listed shares
Dividends (a year)
$0
Latest filing
2025-12-31
Form 3/4/5 transaction date

Holdings

CompanyHeld bySharesPriceValueDividends
REGENERON PHARMACEUTICALS, INC.
REGN · Bd. Co-Chair, President & CSO
Direct 310,460 $774.61 $240.5M —
REGENERON PHARMACEUTICALS, INC.
REGN · Bd. Co-Chair, President & CSO
By 2025 GRAT 200,000 $774.61 $154.9M —
REGENERON PHARMACEUTICALS, INC.
REGN · Bd. Co-Chair, President & CSO
By 2025 GRAT II 200,000 $774.61 $154.9M —
REGENERON PHARMACEUTICALS, INC.
REGN · Bd. Co-Chair, President & CSO
By Trust for Chldn. 180,000 $774.61 $139.4M —
REGENERON PHARMACEUTICALS, INC.
REGN · Bd. Co-Chair, President & CSO
by 2024 GRAT II 101,988 $774.61 $79.0M —
REGENERON PHARMACEUTICALS, INC.
REGN · Bd. Co-Chair, President & CSO
By 2024 GRAT 71,487 $774.61 $55.4M —
REGENERON PHARMACEUTICALS, INC.
REGN · Bd. Co-Chair, President & CSO
by Children 56,048 $774.61 $43.4M —
REGENERON PHARMACEUTICALS, INC.
REGN · Bd. Co-Chair, President & CSO
By 401(k) Plan 5,962 $774.61 $4.6M —
Estimated from SEC Form 3/4/5 holdings and prices from SEC Fails-to-Deliver and Form 13F data. Options and RSUs excluded. Source: U.S. Securities and Exchange Commission (EDGAR). SEC filings